Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2876
Sonic Automotive
SAH
$2B
| $1.24M | ﹤0.01% |
20,486
+8,165
| +66% | +$673K |
2016 Q1
42 quarters
|
|
2877
PUT
Chubb
CB
$141B
| $1.24M | ﹤0.01% |
+3,800
| New | +$1.31M |
2026 Q3
0 quarters
|
|
2878
CTO Realty Growth
CTO
$792M
| $1.23M | ﹤0.01% |
60,257
-71,444
| -54% | -$1.54M |
2022 Q1
18 quarters
|
|
2879
Barrett Business Services
BBSI
$737M
| $1.23M | ﹤0.01% |
40,710
+31,583
| +346% | +$1.12M |
2013 Q2
53 quarters
|
|
2880
iRadimed
IRMD
$1.11B
| $1.23M | ﹤0.01% |
14,278
+1,308
| +10% | +$118K |
2018 Q1
34 quarters
|
|
2881
Marriott Vacations Worldwide
VAC
$4.04B
| $1.23M | ﹤0.01% |
12,012
+5,382
| +81% | +$563K |
2013 Q2
53 quarters
|
|
2882
PUT
EQT Corp
EQT
$33B
| $1.23M | ﹤0.01% |
25,300
-974,700
| -97% | -$51.1M |
2026 Q2
1 quarter
|
|
2883
H.B. Fuller
FUL
$2.73B
| $1.23M | ﹤0.01% |
24,829
+14,008
| +129% | +$780K |
2016 Q1
42 quarters
|
|
2884
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.13B
| $1.22M | ﹤0.01% |
52,729
+21,071
| +67% | +$509K |
2025 Q3
4 quarters
|
|
2885
Clover Health Investments
CLOV
$2.66B
| $1.22M | ﹤0.01% |
282,067
+214,409
| +317% | +$961K |
2024 Q3
8 quarters
|
|
2886
QuantumScape Corp
QS
$2.61B
| $1.22M | ﹤0.01% |
261,611
-121,691
| -32% | -$692K |
2022 Q1
18 quarters
|
|
2887
Intapp
INTA
$3.56B
| $1.21M | ﹤0.01% |
33,496
+13,384
| +67% | +$472K |
2022 Q1
18 quarters
|
|
2888
Melco Resorts & Entertainment
MLCO
$1.57B
| $1.21M | ﹤0.01% |
270,414
+98,013
| +57% | +$514K |
2013 Q2
53 quarters
|
|
2889
Bit Digital
BTBT
$287M
| $1.21M | ﹤0.01% |
742,684
+567,885
| +325% | +$875K |
2022 Q1
18 quarters
|
|
2890
NuScale Power
SMR
$2.15B
| $1.21M | ﹤0.01% |
153,150
-166,241
| -52% | -$1.49M |
2022 Q2
17 quarters
|
|
2891
iShares US Aerospace & Defense ETF
ITA
$12.5B
| $1.21M | ﹤0.01% |
17,451
-247,122
| -93% | -$19.2M |
2026 Q1
2 quarters
|
|
2892
Figure Technology Solutions
FIGR
$5.43B
| $1.2M | ﹤0.01% |
41,751
+24,266
| +139% | +$788K |
2025 Q3
4 quarters
|
|
2893
Ouster
OUST
$2.79B
| $1.2M | ﹤0.01% |
29,793
+6,777
| +29% | +$269K |
2023 Q3
12 quarters
|
|
2894
Dime Commercial Bancshares
DCOM
$1.85B
| $1.2M | ﹤0.01% |
30,470
+1,343
| +5% | +$54.3K |
2022 Q1
18 quarters
|
|
2895
Beta Technologies Inc
BETA
$6.51B
| $1.2M | ﹤0.01% |
54,345
+45,144
| +491% | +$947K |
2026 Q1
2 quarters
|
|
2896
Bel Fuse Inc Class B
BELFB
$3.33B
| $1.19M | ﹤0.01% |
4,887
+2,965
| +154% | +$779K |
2016 Q2
41 quarters
|
|
2897
Blue Acquisition Corp
BACC
$293M
| $1.19M | ﹤0.01% |
+113,400
| New | +$1.2M |
2026 Q3
0 quarters
|
|
2898
Invesco China Technology ETF
CQQQ
$1.81B
| $1.19M | ﹤0.01% |
26,500
| – | – |
2024 Q2
9 quarters
|
|
2899
Immunome
IMNM
$2.25B
| $1.19M | ﹤0.01% |
55,265
+28,914
| +110% | +$718K |
2023 Q4
11 quarters
|
|
2900
DELISTED
Supernus Pharmaceuticals
SUPN
| $1.19M | ﹤0.01% |
27,614
-8,020
| -23% | -$366K |
2013 Q2
53 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.